18β-Glycyrrhetinic Acid Delivered Orally Induces Isolated Lymphoid Follicle Maturation at the Intestinal Mucosa and Attenuates Rotavirus Shedding

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Hendricks, Jay M ^a   Hoffman, Carol ^a,b   Pascual, David W ^a,b   Hardy, Michele E ^a  

^a MONTANA STATE UNIVERSITY   (United States)

^b University of Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR9; CHEMOKINE RECEPTOR CXCR5; GAMMA INTERFERON; GLYCOPROTEIN P 15095; GLYCYRRHETINIC ACID; INTERLEUKIN 10; LYMPHOTOXIN; LYMPHOTOXIN BETA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; SECONDARY LYMPHOID TISSUE CHEMOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; CCL19 GENE; CCL21B GENE; CCR6 GENE; CCR7 GENE; CCR9 GENE; CD3+ T LYMPHOCYTE; CELL AGGREGATION; CELL MATURATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CXCL13 GENE; CXCR5 GENE; DENDRITIC CELL; DRUG ADMINISTRATION ROUTE; DUODENUM; GENE; GENE EXPRESSION; IFNGAMMA GENE; IL10 GENE; ILEUM; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOSTIMULATION; INTESTINE MUCOSA; ISOLATED ORGAN; LAMINA PROPRIA; LTA GENE; LTB GENE; LYMPH FOLLICLE; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; ROTAVIRUS; ROTAVIRUS INFECTION; VIRUS SHEDDING;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, CD19; ANTIGENS, CD3; ANTIGENS, CD45; ANTIGENS, VIRAL; B-LYMPHOCYTES; CELL AGGREGATION; CELL COUNT; GENE EXPRESSION REGULATION; GLYCYRRHETINIC ACID; INTESTINAL MUCOSA; INTESTINE, SMALL; LIGANDS; LYMPHOID TISSUE; MALE; MICE; MICE, INBRED C57BL; PEYER'S PATCHES; RECEPTORS, CHEMOKINE; ROTAVIRUS; ROTAVIRUS INFECTIONS; SYNDECAN-1; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC; VIRUS SHEDDING;

ANIMALIA; GLYCYRRHIZA; ROTAVIRUS;

EID: 84869020507     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049491     Document Type: Article

References (40)

1. Asl MN, Hosseinzadeh H, (2008) Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res 22: 709-724.
2. Schrofelbauer B, Raffetseder J, Hauner M, Wolkerstorfer A, Ernst W, et al. (2009) Glycyrrhizin, the main active compound in liquorice, attenuates pro-inflammatory responses by interfering with membrane-dependent receptor signalling. Biochem J 421: 473-482.
3. Wolkerstorfer A, Kurz H, Bachhofner N, Szolar OH, (2009) Glycyrrhizin inhibits influenza A virus uptake into the cell. Antiviral Res 83: 171-178.
4. Menegazzi M, Di Paola R, Mazzon E, Genovese T, Crisafulli C, et al. (2008) Glycyrrhizin attenuates the development of carrageenan-induced lung injury in mice. Pharmacol Res 58: 22-31.
5. Armanini D, Fiore C, Mattarello MJ, Bielenberg J, Palermo M, (2002) History of the endocrine effects of licorice. Experimental and Clinical Endocrinology and Diabetes 110: 257-261.
6. Fiore C, Eisenhut M, Krausse R, Ragazzi E, Pellati D, et al. (2008) Antiviral effects of Glycyrrhiza species. Phytother Res 22: 141-148.
7. van Rossum TG, Vulto AG, de Man RA, Brouwer JT, Schalm SW, (1998) Review article: glycyrrhizin as a potential treatment for chronic hepatitis C. Aliment Pharmacol Ther. 12: 199-205.
8. Orlent H, Hansen BE, Willems M, Brouwer JT, Huber R, et al. (2006) Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial. J Hepatol 45: 539-546.
9. Ikeda K, Arase Y, Kobayashi M, Saitoh S, Someya T, et al. (2006) A long-term glycyrrhizin injection therapy reduces hepatocellular carcinogenesis rate in patients with interferon-resistant active chronic hepatitis C: a cohort study of 1249 patients. Dig Dis Sci 51: 603-609.
10. Arase Y, Ikeda K, Murashima N, Chayama K, Tsubota A, et al. (1997) The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer 79: 1494-1500.
11. Utsunomiya T, Kobayashi M, Pollard RB, Suzuki F, (1997) Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus. Antimicrob Agents Chemother 41: 551-556.
12. Ni YF, Kuai JK, Lu ZF, Yang GD, Fu HY, et al. (2011) Glycyrrhizin treatment is associated with attenuation of lipopolysaccharide-induced acute lung injury by inhibiting cyclooxygenase-2 and inducible nitric oxide synthase expression. J Surg Res 165: e29-35.
13. Shin YW, Bae EA, Lee B, Lee SH, Kim JA, et al. (2007) In vitro and in vivo antiallergic effects of Glycyrrhiza glabra and its components. Planta Med 73: 257-261.
14. Sun Y, Cai TT, Shen Y, Zhou XB, Chen T, et al. (2009) Si-Ni-San, a traditional Chinese prescription, and its active ingredient glycyrrhizin ameliorate experimental colitis through regulating cytokine balance. Int Immunopharmacol 9: 1437-1443.
15. Di Paola R, Menegazzi M, Mazzon E, Genovese T, Crisafulli C, et al. (2009) Protective effects of glycyrrhizin in a gut hypoxia (ischemia)-reoxygenation (reperfusion) model. Intensive Care Med 35: 687-697.
16. Hattori M, Sakamoto T, Kobashi K, Namba T, (1983) Metabolism of glycyrrhizin by human intestinal flora. Planta Med 48: 38-42.
17. Ukil A, Biswas A, Das T, Das PK, (2005) 18 Beta-glycyrrhetinic acid triggers curative Th1 response and nitric oxide up-regulation in experimental visceral leishmaniasis associated with the activation of NF-kappa B. J Immunol. 175: 1161-1169.
18. Li HE, Qiu JZ, Yang ZQ, Dong J, Wang JF, et al. (2012) Glycyrrhetinic acid protects mice from Staphylococcus aureus pneumonia. Fitoterapia 83: 241-248.
19. Long DRM J, Hendricks JM, Hardy ME, Voyich JM (2012) 18beta-glycyrrhetinic acid inhibits MRSA survival and attenuates virulence gene expression. Antimicrob Agents Chemother accepted pending revision.
20. Burns JW, Krishnaney AA, Vo PT, Rouse RV, Anderson LJ, et al. (1995) Analyses of homologous rotavirus infection in the mouse model. Virology 207: 143-153.
21. Csencsits KL, Walters N, Pascual DW, (2001) Cutting edge: dichotomy of homing receptor dependence by mucosal effector B cells: alpha(E) versus L-selectin. J Immunol 167: 2441-2445.
22. O'Neal CM, Crawford SE, Estes MK, Conner ME, (1997) Rotavirus virus-like particles administered mucosally induce protective immunity. J Virol 71: 8707-8717.
23. Shaneyfelt ME, Burke AD, Graff JW, Jutila MA, Hardy ME, (2006) Natural products that reduce rotavirus infectivity identified by a cell-based moderate-throughput screening assay. Virol J 3: 68.
24. Marchesi F, Martin AP, Thirunarayanan N, Devany E, Mayer L, et al. (2009) CXCL13 expression in the gut promotes accumulation of IL-22-producing lymphoid tissue-inducer cells, and formation of isolated lymphoid follicles. Mucosal Immunol 2: 486-494.
25. Velaga S, Herbrand H, Friedrichsen M, Jiong T, Dorsch M, et al. (2009) Chemokine receptor CXCR5 supports solitary intestinal lymphoid tissue formation, B cell homing, and induction of intestinal IgA responses. J Immunol 182: 2610-2619.
26. Sanderson RD, Lalor P, Bernfield M, (1989) B lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regul 1: 27-35.
27. Hamada H, Hiroi T, Nishiyama Y, Takahashi H, Masunaga Y, et al. (2002) Identification of multiple isolated lymphoid follicles on the antimesenteric wall of the mouse small intestine. J Immunol 168: 57-64.
28. Eberl G, (2005) Inducible lymphoid tissues in the adult gut: recapitulation of a fetal developmental pathway? Nat Rev Immunol 5: 413-420.
29. Pabst O, Herbrand H, Worbs T, Friedrichsen M, Yan S, et al. (2005) Cryptopatches and isolated lymphoid follicles: dynamic lymphoid tissues dispensable for the generation of intraepithelial lymphocytes. Eur J Immunol 35: 98-107.
30. Hardy ME, Hendricks JM, Paulson JM, Faunce NR, (2012) 18beta-glycyrrhetinic acid inhibits rotavirus replication in culture. Virol J 9: 96.
31. Rose J, Franco M, Greenberg H, (1998) The immunology of rotavirus infection in the mouse. Adv Virus Res 51: 203-235.
32. Lorenz RG, Chaplin DD, McDonald KG, McDonough JS, Newberry RD, (2003) Isolated lymphoid follicle formation is inducible and dependent upon lymphotoxin-sufficient B lymphocytes, lymphotoxin beta receptor, and TNF receptor I function. J Immunol 170: 5475-5482.
33. Cerutti A, Puga I, Cols M, (2011) Innate control of B cell responses. Trends Immunol 32: 202-211.
34. McDonald KG, McDonough JS, Newberry RD, (2005) Adaptive immune responses are dispensable for isolated lymphoid follicle formation: antigen-naive, lymphotoxin-sufficient B lymphocytes drive the formation of mature isolated lymphoid follicles. J Immunol 174: 5720-5728.
35. Bouskra D, Brezillon C, Berard M, Werts C, Varona R, et al. (2008) Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 456: 507-510.
36. Suzuki K, Fagarasan S, (2008) How host-bacterial interactions lead to IgA synthesis in the gut. Trends Immunol 29: 523-531.
37. Fagarasan S, Muramatsu M, Suzuki K, Nagaoka H, Hiai H, et al. (2002) Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. Science 298: 1424-1427.
38. Kiss EA, Vonarbourg C, Kopfmann S, Hobeika E, Finke D, et al. (2011) Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 334: 1561-1565.
39. Barouki R, Aggerbeck M, Aggerbeck L, Coumoul X, (2012) The aryl hydrocarbon receptor system. Drug Metabol Drug Interact 27: 3-8.
40. Knoop KA, Newberry RD, (2012) Isolated Lymphoid Follicles are Dynamic Reservoirs for the Induction of Intestinal IgA. Front Immunol 3: 84.